Contact Us

Baxter Infusion Pumps
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Baxter: FDA Seizes Recalled Drug Pumps

Oct 13, 2005 | Business Week

Baxter Healthcare Corp. said Thursday that the Food and Drug Administration seized infusion pumps the medical device maker held at two facilities in Illinois following a recent recall of the products.

The company said about 6,000 Colleague infusion pumps and 850 Syndeo syringe pumps were seized at the facilities. The devices, which deliver controlled amounts of intravenous drugs to patients, were recalled in September after battery problems were linked to four deaths and 10 serious injuries. The seized products had been put on hold by Baxter after the FDA classified the recall as a Class I -- the most serious type -- an action taken when defective products pose a life-threatening risk.

Baxter said it was unable to provide to customers with replacement pumps that have been removed from service. The company continues to work with the FDA on corrective actions concerning the devices. The recall does not affect pumps currently being serviced by Baxter.

About 250,000 Colleague pumps are in use worldwide, with more than 80 percent in the United States. Worldwide, there are about 5,000 Syndeo pumps in use.

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo